| Financial Year |
March 31 2023 |
| Monetary Funds |
396,463,198.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
13,879,308.55 |
| Accounts Receivable |
266,655,328.30 |
| Advances to Suppliers |
162,928,819.22 |
| Other Receivables |
41,732,372.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
162,870,675.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,147,015.52 |
| Total Current Assets |
1,111,563,922.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
291,308,633.25 |
| Investment Properties |
20,863,585.37 |
| Fixed Assetes |
1,572,203,632.53 |
| Under-construction Projects |
83,524,116.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
71,536,719.09 |
| R&D expenses |
-- |
| Goodwill |
1,120,372,955.70 |
| Long-Term Deferred and Prepaid Expenses |
1,014,120.85 |
| Deferred Income Tax Assets |
16,954,488.27 |
| Other Non-Current Assets |
1,804,866.94 |
| Sub-Total of Non-Current Assets |
3,181,889,900.17 |
| Total Assets |
4,293,453,822.38 |
| Short-Term Loans |
753,206,057.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
102,460,000.00 |
| Accounts Payable |
201,687,548.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
36,507,835.63 |
| Taxes Payable |
33,187,017.70 |
| Interest Payable |
-- |
| Dividend Payable |
18,487,108.26 |
| Other payables |
313,390,545.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
198,007,567.73 |
| Other Current Liabilities |
16,791,280.60 |
| Sub-Total of Current Liabilities |
1,793,992,497.95 |
| Long-term Loans |
93,710,666.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
510,142,525.40 |
| Special Payable |
-- |
| Estimatied Liabilities |
10,496,371.55 |
| Deferred Income Tax Liabilities |
18,910,794.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
652,664,826.13 |
| Total Liabilities |
2,446,657,324.08 |
| Paid-In Capital(Or Share Stock) |
464,374,926.00 |
| Capital Surplus |
1,035,082,990.49 |
| Surplus Reserve |
27,679,699.10 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
66,704,785.31 |
| Minority Stockholder's Interest |
237,424,107.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,609,372,390.89 |
| Owner's Equity（Stockholder's Equity） |
1,846,796,498.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,293,453,822.38 |
